Empagliflozin attenuates adverse outcomes of acute ischemic heart failure by targeting NLRP3/IL1β mediated macrophage polarization and inflammatory response
The role of SGLT2 inhibitors in acute heart failure and associated mechanisms remain unclear. To elucidate the impact of empagliflozin on acute ischemic heart failure and its underlying mechanisms. Left anterior descending coronary artery of male C57BL6/J mice was ligated permanently to induce myoca...